Crude Oil Gains Over 2%; S&P Global Raises Profit Outlook
Portfolio Pulse from Lisa Levin
S&P Global Inc. reported better-than-expected Q3 results and raised its annual profit outlook. The company's adjusted earnings were $3.21 per share, beating market estimates of $3.05 per share. Sales came in at $3.08 billion versus estimates of $3.02 billion. The company raised its 2023 adjusted earnings forecast from $12.35-$12.55 to $12.50-$12.60. Other companies such as Aware, Inc., Rocky Brands, Inc., and Lemonade, Inc. also reported strong quarterly results. However, Outlook Therapeutics, Inc., Confluent, Inc., and POET Technologies Inc. saw their shares drop after various announcements.
November 02, 2023 | 6:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aware, Inc. reported strong quarterly sales results, which could positively impact its stock price.
Aware, Inc.'s strong quarterly sales results indicate good performance, which is likely to be viewed positively by investors and could drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Lemonade, Inc. reported strong Q3 results, which could positively impact its stock price.
Lemonade's strong Q3 results indicate good performance, which is likely to be viewed positively by investors and could drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Rocky Brands, Inc. reported better-than-expected Q3 results, which could positively impact its stock price.
Rocky Brands' better-than-expected Q3 results indicate strong performance, which is likely to be viewed positively by investors and could drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
S&P Global reported better-than-expected Q3 results and raised its annual profit outlook, which could positively impact its stock price.
S&P Global's better-than-expected Q3 results and raised profit outlook indicate strong performance, which is likely to be viewed positively by investors and could drive the stock price up.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Confluent, Inc. shares were down after the company reported Q3 results, which could negatively impact its stock price.
Confluent's Q3 results announcement seems to have been received negatively by the market, which could drive the stock price down.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Outlook Therapeutics, Inc. shares dropped after the FDA informed the company that an additional clinical trial would be required for the approval of ONS-5010, which could negatively impact its stock price.
The FDA's requirement for an additional clinical trial for ONS-5010 could delay its approval, which is likely to be viewed negatively by investors and could drive the stock price down.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
POET Technologies Inc. shares fell after the company initiated a public offering in the US and a non-brokered offering in Canada, which could negatively impact its stock price.
POET Technologies' initiation of a public offering in the US and a non-brokered offering in Canada could dilute existing shares, which is likely to be viewed negatively by investors and could drive the stock price down.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100